Anúncio
Anúncio
MIST
Milestone Pharmaceuticals Inc. Common Shares
2.04
USDPatrocinado
-0.15
-6.62%
09 de jan., 15:59 UTC -5
Encerrado
Pós-Mercado
2.05
0.00
+0.24%
Relatórios de Lucros MIST
Rácio de surpresa positiva
MIST separação 16 de 26 últimas estimativas.
62%
Próximo Relatório
Data do Próximo Relatório
11 de mar. de 2026
Estimate for Q4 25 (Revenue/ EPS)
--
/-$0.16
Mudanças implicadas de Q3 25 (Revenue/ EPS)
--
/+33.33%
Mudanças implicadas de Q4 24 (Revenue/ EPS)
--
/-15.79%
Milestone Pharmaceuticals Inc. Common Shares earnings per share and revenue
On 12 de nov. de 2025, MIST reported earnings of -0.12 USD per share (EPS) for Q3 25, beating the estimate of -0.16 USD, resulting in a 28.27% surprise. Revenue reached --, compared to an expected --, with a 0.00% difference. The market reacted with a +1.05% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 7 analistas forecast an EPS of -0.16 USD, with revenue projected to reach -- USD, implying an aumentar of 33.33% EPS, and aumentar of 0.00% in Revenue from the last quarter.
FAQ
What were Milestone Pharmaceuticals Inc. Common Shares's earnings and revenue for the latest quarter Q3 2025?
For Q3 2025, Milestone Pharmaceuticals Inc. Common Shares reported EPS of -$0.12, beating estimates by 28.27%, and revenue of $0.00, 0% as expectations.
How did the market react to Milestone Pharmaceuticals Inc. Common Shares's Q3 2025 earnings?
The stock price moved up 1.05%, changed from $1.91 before the earnings release to $1.93 the day after.
When is Milestone Pharmaceuticals Inc. Common Shares expected to report next?
The next earning report is scheduled for 11 de mar. de 2026.
What are the forecasts for Milestone Pharmaceuticals Inc. Common Shares's next earnings report?
Based on 7
analistas, Milestone Pharmaceuticals Inc. Common Shares is expected to report EPS of -$0.16 and revenue of -- for Q4 2025.
Which companies are reporting earnings today?
Verificar FXEmpire's Earnings Calendar for today's list of reporting companies.
Anúncio